awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38964908-0C373D20-0574-4A29-8EF8-B6C0072947C7
Q38964908-0C373D20-0574-4A29-8EF8-B6C0072947C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38964908-0C373D20-0574-4A29-8EF8-B6C0072947C7
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.
P2860
Q38964908-0C373D20-0574-4A29-8EF8-B6C0072947C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38964908-0C373D20-0574-4A29-8EF8-B6C0072947C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e0c8fbf96dc6239a9e60d5840dff2cd20ae152ea
P2860
A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.